Althea hits a new personal best in August

Althea hits a new personal best in August

Medicinal cannabis company Althea (ASX: AGH) has broken its own records during August, with more patients than ever now receiving the company's pharmaceuticals.

The company saw 392 patients prescribed Althea products during August, at a rate of 18 patients per business day, representing the largest number of new patients to be prescribed Althea products in a single month.

This means 1,926 patients have now been prescribed Althea medicinal cannabis products in Australia, with 296 doctors actively prescribing the company's product.

"Althea is demonstrating that the medicinal cannabis industry in Australia has enormous potential - especially with the support of the medical community which continues to gain momentum," says Althea CEO Josh Fegan.

"Althea is focussed on medical education and this is proving that by working closely with healthcare professionals, medicinal cannabis can reach an ever-increasing number of patients."

Read more: Australia's top 20 cannabis companies

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

From pandemic side hustle to multi-million dollar business: Meet Ling Fung
Partner Content
Ask any parent, and they’ll tell you: preparing for a new baby is no easy task.&n...
Metro Baby
Advertisement

Related Stories

Dose of caffeine for Retail Food Group shares on profit outlook

Dose of caffeine for Retail Food Group shares on profit outlook

Shares in Retail Food Group (ASX: RFG) perked up today as the Gold ...

Insurance cost for floods and storms hits $12.3 billion since January 2020

Insurance cost for floods and storms hits $12.3 billion since January 2020

With the February-March floods in Southeast QLD and NSW now classed...

CEFC slates $70m for Melbourne timber high-rise T3 Collingwood

CEFC slates $70m for Melbourne timber high-rise T3 Collingwood

A development led by global real estate group Hines that is set to ...

Is attribution software killing our creativity?

Is attribution software killing our creativity?

As digital marketing continues to evolve at rapid speeds, businesse...